Institutional Manager · CIK 0000872589
REGENERON PHARMACEUTICALS, INC.
Tarrytown, NY · File #028-24826
Latest AUM
$33.8M
Positions
2
Top-10 Concentration
100.0%
Filings
5
Portfolio Value Over Time
2024-12
2025-03
2025-06
2025-09
2025-12
Biggest QoQ Changes
Ranked by conviction flow (share change × current price) so mark-to-market moves don't dominate. Price effect column shows how much of the $ change was just the stock moving.
| Action | Issuer | Ticker / CUSIP | Δ Shares | Flow ($) | Price Effect |
|---|---|---|---|---|---|
| EXITED | Alnylam Pharmaceuticals, Inc. | 02043Q107 | -1,392,303 | -$634.9M | $0 |
| REDUCE | Adicet Bio, Inc. | ACET | -907,672 | -$7.6M | +$7.4M |
| EXITED | Adverum Biotechnologies, Inc. | 00773U207 | -180,909 | -$819,518 | $0 |
| REDUCE | Intellia Therapeutics, Inc. | NTLA | 0 | $0 | -$30.7M |
Sector Allocation
Filing History
- 13F HOLDINGS REPORTQ/E Dec 20252 pos · $33.8M
- 13F HOLDINGS REPORTQ/E Sep 20254 pos · $700.4M
- 13F HOLDINGS REPORTQ/E Jun 20254 pos · $1.49B
- 13F HOLDINGS REPORTQ/E Mar 20256 pos · $1.23B
- 13F HOLDINGS REPORTQ/E Dec 20246 pos · $1.09B
Top 2 Holdings — Dec 2025
| # | Issuer | Ticker | Shares | Value | % of Portfolio |
|---|---|---|---|---|---|
| 1 | Intellia Therapeutics, Inc. | NTLA | 3,702,995 | $33.3M | 98.49% |
| 2 | Adicet Bio, Inc. | ACET | 60,511 | $509,503 | 1.51% |